Company profile
ARC Medical Inc.
Improving surgical patient outcomes by preventing internal adhesions.
- Industry
- Medical Equipment Manufacturing
- Employees
- 17
- Headquarters
- Richmond (Vancouver), BC
- LinkedIn followers
- 1,768
- Office locations
- 1
ARC Medical Inc. company summary
ARC Medical Inc. is a company in the Medical Equipment Manufacturing industry, headquartered in Richmond (Vancouver), BC. On LinkedIn the company has around 17 employees and 1,768 followers.
What technology does ARC Medical Inc. use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About ARC Medical Inc.
ARC is improving surgical patient outcomes by preventing internal adhesions. ARC is preventing orthopedic knee & shoulder and abdominal & gynecologic surgical adhesions, also known as internal scars, with the Company's clinical stage, Class III, US PMA regulatory pathway, JOCOAT™ and IPCOAT™ liquid surgical adhesion barrier medical devices. Surgical adhesions are a large, unmet medical need with a total addressable market of greater than 11M patients and USD $11B annually. JOCOAT™ and IPCOAT™ are easily and rapidly used in multiple types of arthroscopic, arthroplasty, laparoscopic and open surgeries. JOCOAT™ and IPCOAT™ are backed by: - favorable surgical patient data (N=35); - positive safety clinical trial data in healthy volunteers (N=76); - 5 composition of matter patents issued in the US that provide exclusivity through 2039+ ARC has raised USD $22M in equity and an additional USD $18M in non-dilutive revenues and grants, for a total of USD $40M. ARC is past midway through treating patients with JOCOAT™ in an orthopedic knee anterior cruciate ligament (ACL) repair surgery patient clinical trial (N=74) and just received approvals to start a clinical trial for IPCOAT™ in gynecological endometriosis surgery patients (N=33). The near term clinical data readouts from these two clinical trials are expected to be major value drivers for ARC, with the JOCOAT™ clinical data readout expected in December 2026 and the IPCOAT™ clinical data readout expected mid 2027. Direct message our CEO, Chris Springate, to learn more about ARC’s current clinical trials and near term clinical data readouts... ...including if you are a patient, orthopedic surgeon, gynecologic surgeon, abdominal surgeon, medtech company, medical device company, corporate venture capitalist, venture capitalist, family office, high net worth individual investor or angel investor.
Where is ARC Medical Inc. located?
ARC Medical Inc. lists 1 location.
Compare companies similar to ARC Medical Inc.
More companies in Medical Equipment Manufacturing.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
ARC Medical Inc. arcmedinc.com | Medical Equipment Manufacturing | 17 | - | Richmond (Vancouver), BC |
 Boston Scientific bostonscientific.com | Medical Equipment Manufacturing | 54,970 | - | Marlborough, MA |
 BD bd.com | Medical Equipment Manufacturing | 46,224 | - | Franklin Lakes, New Jersey |
 Baxter International Inc. baxter.com | Medical Equipment Manufacturing | 39,218 | - | Deerfield, Illinois |
 Alcon alcon.com | Medical Equipment Manufacturing | 27,667 | - | Geneva, Switzerland |
 Smith+Nephew smith-nephew.com | Medical Equipment Manufacturing | 19,271 | - | Watford, Hertfordshire, GB |
 Zimmer Biomet EMEA zimmerbiomet.com | Medical Equipment Manufacturing | 19,125 | - | Warsaw, Indiana |
 Olympus Corporation olympus-global.com | Medical Equipment Manufacturing | 13,703 | 1919 | Shinjuku-ku, Tokyo |
 Intuitive intuitive.com | Medical Equipment Manufacturing | 13,091 | 1995 | California, 94086 |
 Medline Australia medline.com | Medical Equipment Manufacturing | 18,899 | - | Northfield, IL |
 Edwards Lifesciences edwards.com | Medical Equipment Manufacturing | 14,197 | 1958 | Irvine, CA |
Frequently asked questions about ARC Medical Inc.
What does ARC Medical Inc. do?
ARC is improving surgical patient outcomes by preventing internal adhesions. ARC is preventing orthopedic knee & shoulder and abdominal & gynecologic surgical adhesions, also known as internal scars, with the Company's clinical stage, Class III, US PMA regulatory pathway, JOCOAT™ and IPCOAT™ liquid surgical adhesion barrier medical devices. Surgical adhesions are a large, unmet medical need with a total addressable market of greater than 11M patients and USD $11B annually. JOCOAT™ and IPCOAT™ are easily and rapidly used in multiple types of arthroscopic, arthroplasty, laparoscopic and open surgeries. JOCOAT™ and IPCOAT™ are backed by: - favorable surgical patient data (N=35); - positive safety clinical trial data in healthy volunteers (N=76); - 5 composition of matter patents issued in the US that provide exclusivity through 2039+ ARC has raised USD $22M in equity and an additional USD $18M in non-dilutive revenues and grants, for a total of USD $40M. ARC is past midway through treating patients with JOCOAT™ in an orthopedic knee anterior cruciate ligament (ACL) repair surgery patient clinical trial (N=74) and just received approvals to start a clinical trial for IPCOAT™ in gynecological endometriosis surgery patients (N=33). The near term clinical data readouts from these two clinical trials are expected to be major value drivers for ARC, with the JOCOAT™ clinical data readout expected in December 2026 and the IPCOAT™ clinical data readout expected mid 2027. Direct message our CEO, Chris Springate, to learn more about ARC’s current clinical trials and near term clinical data readouts... ...including if you are a patient, orthopedic surgeon, gynecologic surgeon, abdominal surgeon, medtech company, medical device company, corporate venture capitalist, venture capitalist, family office, high net worth individual investor or angel investor.
How many employees does ARC Medical Inc. have?
ARC Medical Inc. has around 17 employees on LinkedIn.
Where is ARC Medical Inc. headquartered?
ARC Medical Inc. is headquartered in Richmond (Vancouver), BC.
Build a lead list from companies like ARC Medical Inc.
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.